Another showdown is looming between a leading academic medical center and a payer it seemingly can’t live without, and once again it’s about Medicaid.
Another showdown is looming between a leading academic medical center and a payer it seemingly can’t live without, and once again it’s about Medicaid.
This time the 2 sides are Cleveland Clinic, which today was making news after performing its first full face transplant, and CareSource, a nonprofit health insurer that covers members in 4 states.
This week, the insurer, which offers the largest Medicaid managed care plan in Ohio, will send members required notices that their contact could end September 1, 2017, as required by the Ohio Department of Medicaid. The planned notices were reported by the Cleveland Plain Dealer.
“Regrettably, we recently received notice from CareSource that they may terminate our relationship,” the Clinic said in a statement released to the Plain Dealer. “In the event the relationship ends, patients may need another Medicaid plan to access Cleveland Clinic. We will work with CareSource to provide continuity of care for those patients.”
No details have been offered for pthe otential split, but these kinds of disputes between major academic medical centers and insurers over Medicaid rates have become increasingly common. Earlier this month, the Minnesota attorney general had to broker an agreement between the state’s largest pediatric health system, Children’s Minnesota, and Blue Cross Blue Shield of Minnesota, when the insurer tried to negotiate lower rates, and the health system refused.
When deals cannot be reached, academic health systems may find themselves left out of narrow networks and insurers look to find savings; health systems in urban areas or those that serve high numbers of complex cases are often in fewer networks, according to research by the Robert Wood Johnson Foundation.
If a deal between Cleveland Clinic and CareSource can’t be reached, patients who want to use the Clinic would have to 1 of 3 other Medicaid managed care plans accepted there. Or, patients could stay with CareSource and use other health systems in the Cleveland area.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
ACA Dependent Coverage Extension and Young Adults’ Substance-Associated ED Visits
September 15th 2025This study examines the impact of the Affordable Care Act (ACA) on substance-associated emergency department (ED) visits among young adults, revealing reduced alcohol-associated visits but unchanged opioid-associated visits.
Read More